rawfin.tv
FDA Approves Daraxonrasib for Pancreatic Cancer Treatment
Top Storiesstocks🟠 Score 8AI Generated

FDA Approves Daraxonrasib for Pancreatic Cancer Treatment

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

The FDA has approved Daraxonrasib, a new drug poised to revolutionize pancreatic cancer treatment. Clinical trials showed patients on the pill lived twice as long as those on chemotherapy.

FDADrug-ApprovalPancreatic-CancerHealthcarePharmaceuticals

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks